The Future of Pharmaceutical Psychedelics in Mental Health Treatment
Director for Counter Narcotics Technology
In this episode we speak with Erica Siegal, a licensed clinical social worker, professional harm reductionist community organizer, psychedelic-assisted psychotherapist, and founder of NEST Harm Reduction Consulting in California. She worked as a psychotherapist researcher on the phase two and phase three FDA approved MDMA assisted psychotherapy clinical trials from 2014 to 2019.
Join us as we discuss:
Emerging findings about psychedelic treatments for individuals with mental health issues
The pace of psychedelic substance regulation on a state and federal level
Psychedelic substance interventions in the case of opioid addiction treatments
Listen and subscribe on your favorite podcast player: